SCHEMBL7213872

SCHEMBL7213872

Clc1ccc2c(ccn2C2CCN(CCC3Cc4ccccc4C3)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.49
SLC6A4 P31645 7/20 0.49
HTR2A P28223 8/20 0.46
HTR7 P34969 6/20 0.46
DRD3 P35462 6/20 0.46
HTR1A P08908 5/20 0.46
HTR2C P28335 3/20 0.46
DRD4 P21917 1/20 0.46
SCD O00767 1/20 0.43
DRD1 P21728 1/20 0.41
HTR2B P41595 3/20 0.39
PRMT5 O14744 1/20 0.39
KCNH2 Q12809 2/20 0.38
MCHR1 Q99705 1/20 0.38
SLC6A2 P23975 3/20 0.37
ACHE P22303 1/20 0.37
HRH1 P35367 2/20 0.36
ADRA2A P08913 2/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7220166 0.86 DRD2 (0.66) DRD2SLC6A4HTR2AHTR7DRD3
SCHEMBL6789672 0.78 SCD (0.55) DRD2SLC6A4HTR2AHTR7HTR1A
SCHEMBL7214489 0.74 DRD2 (0.41) DRD2SLC6A4HTR2AHTR7DRD3
SCHEMBL7221068 0.72 DRD2 (0.45) DRD2SLC6A4HTR2AHTR7DRD3
SCHEMBL8111320 0.71 SCD (0.47) DRD2SLC6A4HTR2AHTR7HTR2C
SCHEMBL20364988 0.69 DRD2 (0.72) DRD2SLC6A4HTR2AHTR7DRD3
SCHEMBL4991364 0.69 HRH3 (0.47) DRD2SLC6A4HTR2AHTR7SCD
SCHEMBL4676971 0.69 SCD (0.45) SLC6A4HTR2AHTR2CSCDHTR2B
SCHEMBL4676967 0.69 SCD (0.47) DRD2SLC6A4HTR2AHTR2CSCD
SCHEMBL6796534 0.68 SCD (0.38) DRD2SLC6A4HTR2AHTR7HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6552044-B2 Dopamine receptors H. LUNDBECK A/S (DK) 2003-04-22 US disclosed
EP-0946542-B1 INDANE OR DIHYDROINDOLE DERIVATIVES LUNDBECK & CO AS H (DK) 2002-10-09 EP disclosed
US-6352988-B2 HIGH AFFINITY FOR D4 RECEPTORS; TREATMENT OF SCHIZOPHRENIA, OTHER PSYCHOSES, ANXIETY DISORDERS, DEPRESSION, ALCOHOL ABUSE, IMPULSE CONTROL DISORDERS, AGGRESSION H. LUNDBECK A/S (DK) 2002-03-05 US disclosed
US-20010021777-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-13 US disclosed
US-20010020095-A1 Indane or dihydroindole derivatives H. LUNDBECK A/S (DK) 2001-09-06 US disclosed
US-6262087-B1 HAVE HIGH AFFINITY FOR D4 RECEPTORS; USEFUL IN THE TREATMENT OF CERTAIN PSYCHIATRIC AND NEUROLOGIC DISORDERS, INCLUDING PSYCHOSIS, DEPRESSION AND ANXIETY. H. LUNDBECK A/S (DK) 2001-07-17 US disclosed
EP-0946542-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H. LUNDBECK A/S (DK) 1999-10-06 EP disclosed
WO-1998028293-A1 INDANE OR DIHYDROINDOLE DERIVATIVES H.LUNDBECK A/S (DK) 1998-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010020095-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 DRD2 14/4885SLC6A4 40/4885HTR2A 32/4885
US-20010021777-A1 Indane or dihydroindole derivatives HTR4, GPR4, GPR174 DRD2 14/4885SLC6A4 40/4885HTR2A 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.